BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38287022)

  • 1. CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma.
    Li Y; Yang C; Xie L; Shi F; Tang M; Luo X; Liu N; Hu X; Zhu Y; Bode AM; Gao Q; Zhou J; Fan J; Li X; Cao Y
    Cell Death Dis; 2024 Jan; 15(1):95. PubMed ID: 38287022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK
    Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CaMKII exacerbates heart failure progression by activating class I HDACs.
    Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
    J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of tumor suppressor gene Cyld is upregulated by histone deacetylace inhibitors in human hepatocellular carcinoma cell lines.
    Kotantaki P; Mosialos G
    Cell Biochem Funct; 2016 Oct; 34(7):465-468. PubMed ID: 27570065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYLD deficiency enhances metabolic reprogramming and tumor progression in nasopharyngeal carcinoma via PFKFB3.
    Wang L; Lin Y; Zhou X; Chen Y; Li X; Luo W; Zhou Y; Cai L
    Cancer Lett; 2022 Apr; 532():215586. PubMed ID: 35131382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of Class I Histone Deacetylases (HDAC) by Human Dendritic Cells after Alcohol Consumption and In Vitro Alcohol Treatment and Their Implication in Oxidative Stress: Role of HDAC Inhibitors Trichostatin A and Mocetinostat.
    Agudelo M; Figueroa G; Parira T; Yndart A; Muñoz K; Atluri V; Samikkannu T; Nair MP
    PLoS One; 2016; 11(6):e0156421. PubMed ID: 27249803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation.
    Huang Z; Tan Y
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
    Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
    Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.
    Yang Q; Falahati A; Khosh A; Mohammed H; Kang W; Corachán A; Bariani MV; Boyer TG; Al-Hendy A
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target.
    Cheng C; Yang J; Li SW; Huang G; Li C; Min WP; Sang Y
    Cell Death Dis; 2021 Feb; 12(2):137. PubMed ID: 33542203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.
    Kee HJ; Kook H
    J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway.
    Ding S; Gao Y; Lv D; Tao Y; Liu S; Chen C; Huang Z; Zheng S; Hu Y; Chow LK; Wei Y; Feng P; Dai W; Wang X; Xia Y
    EBioMedicine; 2022 Jul; 81():104100. PubMed ID: 35689852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism.
    Hui KF; Chiang AK
    Int J Cancer; 2014 Dec; 135(12):2950-61. PubMed ID: 24771510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effects of class I histone deacetylases on hippocampal neuroinflammatory regulation in aging mice with postoperative cognitive dysfunction.
    Yang CX; Bao F; Zhong J; Zhang L; Deng LB; Sha Q; Jiang H
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10194-10202. PubMed ID: 33090427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic domain mutation in CYLD inactivates its enzyme function by structural perturbation and induces cell migration and proliferation.
    Johari T; Maiti TK
    Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):2081-2089. PubMed ID: 29807073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases.
    Chen CQ; Yu K; Yan QX; Xing CY; Chen Y; Yan Z; Shi YF; Zhao KW; Gao SM
    Carcinogenesis; 2013 Jul; 34(7):1442-9. PubMed ID: 23430957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Cellular Model Mimicking Specific HDAC Inhibitors.
    Hess L; Moos V; Seiser C
    Methods Mol Biol; 2023; 2589():51-73. PubMed ID: 36255617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.
    Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.